Skip to content
  • info@BioLifeSolutions.com
  • 1.866.424.6543
  • Toggle search form
  • Toggle shopping cart 0

    Cart

  • Products
    • CryoStor®
      • CryoStor CS10
      • CryoStor CS5
      • CryoStor CS2
      • CryoStor CSB
    • HypoThermosol®
      • HypoThermosol®
      • HypoThermosol for Hair
    • ThawSTAR® Products
      • ThawSTAR CB
      • ThawSTAR CFT2
      • AT6
      • CFT1.5
      • CFT2 Confirmation Vials
      • Warranty and PM
      • IOP Qualification Packet
      • BioT ULT Transporter
      • BioT LN2 Transporter
      • BioT ULT Mobile Workstation
    • BloodStor®
      • BloodStor 100
      • BloodStor 55-5
      • BloodStor 27
    • Cell Thawing Media®
      • 10% Dextran 40 (IN 0.9% NaCl)
      • 10% Dextran 40 (IN 5% Dextrose)
    • All Products
  • Resources
    • Certificate of Analysis
    • Blog
    • Events
    • BioPreservation Today
    • White Papers
    • Press Releases
  • Evidence
    • Resource Links
  • Company
    • About
    • Leadership
    • Board of Directors
    • Scientific Advisory Board
    • Quality Management System
    • Distributors
    • Current Job Openings
  • Investors
    • Investors Home
    • Governance
    • Press Releases
    • Financials
    • Stock Information
    • Management Team
    • Investor Contact
  • Contact
    • General Inquiries
    • ThawSTAR Inquiries
    • Master File Request
    • SDS Request Form
    • Sample Request
    • evo Support Request
  • Ask the Scientists
  • ORDER
Close navigation
  • Primary Menu
logo

BioLife Solutions

Biopreservation Tools For Cells, Tissues, and Organs

Close search

Search

Search for:
Home/Blog/Tag: “Abazari”

Tag: Abazari

Process development considerations for cryopreservation of cellular therapies

Abazari, A.  Process development considerations for cryopreservation of cellular therapies.  Cell & Gene Therapy Insights. 2019; 5(9), 1151–1167.  doi: 10.18609/cgti.2019.122

Read More

The Impact of feeding regimen and cell cycle on post-thaw recovery in a human T-cell model

The Impact of feeding regimen and cell cycle on post-thaw recovery in a human T-cell model

Read More

Process Optimization for CD3+ T-Cell Formulation and Cryopreservation

Process Optimization for CD3+ T-Cell Formulation and Cryopreservation

Read More

The Effect of Cryomedia Selection and Transient Warming Events on Post-Cryopreservation Human MSC Function

The Effect of Cryomedia Selection and Transient Warming Events on Post-Cryopreservation Human MSC Function

Read More

Biopreservation Best Practices: A Cornerstone in the Supply Chain of Cell-based Therapies – MSC Model Case Study

Abazari A, Hawkins BJ, Clarke DM, Mathew AJ. Biopreservation Best Practices: A Cornerstone in the Supply Chain of Cell-based Therapies – MSC Model Case Study.  Cell Gene Therapy Insights 2017; 3(10), 853-871. DOI: 10.18609/cgti.2017.082

Read More

Biopreservation Best Practices: A Cornerstone in the Supply Chain of Cell-based Therapies – MSC Model Case Study

Abazari A, Hawkins BJ, Clarke DM, Mathew AJ. Biopreservation Best Practices: A Cornerstone in the Supply Chain of Cell-based Therapies – MSC Model Case Study.  Cell Gene Therapy Insights 2017; 3(10), 853-871. DOI: 10.18609/cgti.2017.082

Read More

Methods for the Derivation and Use of Cardiomyocytes from Human Pluripotent Stem Cells Methods.

Zhu WZ, Van Biber B, Laflamme MA. Methods for the Derivation and Use of Cardiomyocytes from Human Pluripotent Stem Cells. Methods Mol Biol. Author manuscript; available in PMC Jun 4, 2014. Published in final edited form as: Methods Mol Biol. 2011; 767: 419–431. doi: 10.1007/978-1-61779-201-4_31

Read More
Search for:

Blog Archives

Signup Area

    Sign Up for Email Updates

    Biolife Logo

    • Products
    • Company
    • Evidence
    • Investors
    • Blog
    • Ask the Scientists
    • Press Releases
    • Contact
    © 2019 BioLifeSolutions Inc.  All Rights Reserved    |    Terms & Conditions    |    Privacy
    • twitter
    • linkedin
    • facebook